Seth Klarman's position in Jazz Pharmaceuticals plc is currently worth $90.9 Million. That's 2.97% of their equity portfolio (7th largest holding). The investor owns 1.30% of the outstanding Jazz Pharmaceuticals plc stock. The investor's estimated purchase price is $117 Million, resulting in a loss of 22%.